Serious adverse events · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) showed no clear difference in serious adverse events compared with static cold storage (SCS) (moderate certainty).
1 finding from 1 review
Graft survival · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) leads to lower graft survival compared with static cold storage (SCS) (high certainty).
1 finding from 1 review
Ischaemic biliary complications total · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) leads to lower ischaemic biliary complications total compared with static cold storage (SCS) (high certainty).
1 finding from 1 review
Ischaemic biliary complications (donated following brain death (DBD)) · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) showed no clear difference in ischaemic biliary complications (donated following brain death (DBD)) compared with static cold storage (SCS); GRADE not reported.
1 finding from 1 review
Ischaemic biliary complications (donated following circulatory death (DCD)) · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) led to lower ischaemic biliary complications (donated following circulatory death… compared with static cold storage (SCS); GRADE not reported.
1 finding from 1 review
Early allograft dysfunction total · liver transplant recipients
Hypothermic oxygenated perfusion (HOPE) leads to lower early allograft dysfunction total compared with static cold storage (SCS) (high certainty).
1 finding from 1 review
Adverse events considered non‐serious · liver transplant recipients
1 finding from 1 review
Death at hospital discharge · preterm infants < 37 weeks' gestational age requiring conventional mechanical ventilation for respiratory distress syndrome
Oxygen‐guided lung‐recruitment maneuver showed no clear difference in mortality by hospital discharge compared with routine care (low certainty).
1 finding from 1 review
Bronchopulmonary dysplasia · preterm infants < 37 weeks' gestational age requiring conventional mechanical ventilation for respiratory distress syndrome
Oxygen‐guided lung‐recruitment maneuver showed no clear difference in bronchopulmonary dysplasia compared with routine care (low certainty).
1 finding from 1 review
Duration of invasive ventilatory support · preterm infants < 37 weeks' gestational age requiring conventional mechanical ventilation for respiratory distress syndrome
1 finding from 1 review
Progression to oxygen therapy · people with confirmed COVID‐19
Favipiravir showed no clear difference in progression to oxygen therapy compared with no treatment, supportive treatment, or other antiviral treatment (low certainty).
1 finding from 1 review
Chronic lung disease · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in chronic lung disease (oxygen supplementation at 36 weeks) compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Death (before hospital discharge) or BPD (supplemental oxygen/respiratory support at 36 weeks' postmenstrual age if born < 32 weeks' gestation, or 28 days if born ≥ 32 weeks' gestation) · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in death (before hospital discharge) or BPD(supplemental… compared with continuous positive airway pressure (low certainty).
1 finding from 1 review
BPD (supplemental oxygen/respiratory support at 36 weeks' postmenstrual age if born < 32 weeks' gestation, or 28 days if born ≥ 32 weeks' gestation) · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in BPD (supplemental oxygen/respiratory support at 36 weeks'… compared with nasal intermittent positive pressure ventilation (low certainty).
1 finding from 1 review
BPD (supplemental oxygen/respiratory support at 36 weeks' postmenstrual age if born < 32 weeks' gestation, or 28 days if born ≥ 32 weeks' gestation) · preterm infants requiring primary respiratory support
Nasal high flow showed no clear difference in BPD (supplemental oxygen/respiratory support at 36 weeks'… compared with continuous positive airway pressure (low certainty).
1 finding from 1 review
Death (before hospital discharge) or BPD (supplemental oxygen/respiratory support at 36 weeks' postmenstrual age if born < 32 weeks' gestation, or 28 days if born ≥ 32 weeks' gestation) · preterm infants requiring primary respiratory support
It is very uncertain whether nasal high flow changes death (before hospital discharge) or BPD (supplemental… compared with nasal intermittent positive pressure ventilation (very low certainty).
1 finding from 1 review
Oxygen requirement at 36 weeks' postmenstrual age · term and preterm infants resuscitated at birth, using positive pressure ventilation
Nasal interfaces (single nasal prong, binasal prongs (long or… showed no clear difference in the need for supplemental oxygen at 36 weeks' corrected gestational… compared with face mask (low certainty).
1 finding from 1 review
Chronic lung disease · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of any form of respiratory support (any form of non‐invasive respiratory support with or without supplemental oxygen) · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
1 finding from 1 review
Duration of any form of respiratory support (any form of non‐invasive respiratory support with or without supplemental oxygen) · respiratory support in term infants (infants ≥ 37 weeks gestational age to the end of the neonatal period (up to 1 month postnatal age))
1 finding from 1 review